Skip to main content
. Author manuscript; available in PMC: 2015 Sep 9.
Published in final edited form as: Am J Transplant. 2015 Mar 11;15(6):1623–1631. doi: 10.1111/ajt.13144

Table 5.

Allograft function at 6 months by donor AKI and stratified by DGF status

6-month SCr, mg/dl 6-month eGFR, ml/min/1.73m2
All recipients
(n=2567)		 Recipients
with DGF
(n=800)		 Recipients
without DGF
(n=1767)		 All recipients
(n=2567)		 Recipients
with DGF
(n=800)		 Recipients
without DGF
(n=1767)
No Donor AKI (N=1945) 1.34 [1.07, 1.7] 1.52 [1.27, 2.1] 1.3 [1.0, 1.6] 55 [41, 72] 46 [29, 60] 59 [45, 75]
Stage 1 AKI (N=403) 1.35 [1.1, 1.8] 1.5 [1.2, 1.95] 1.3 [1.1, 1.6] 54 [40, 68] 49 [32, 64] 56 [46, 72]
Stage 2 AKI (N=120) 1.5 [1.15, 1.75] 1.54 [1.3, 1.85] 1.3 [1.0, 1.65] 53 [38, 67] 52 [36, 59] 55 [40, 74]
Stage 3 AKI (N=99) 1.3 [1.1, 1.68] 1.3 [1.1, 1.75] 1.3 [0.97, 1.6] 59 [40, 73] 58 [39, 71] 59 [41, 78]
P-value 1 0.276 0.049 0.497 0.377 0.060 0.537

Values are median [interquartile range]. AKI, acute kidney injury; DGF, delayed graft function; eGFR, estimated glomerular filtration rate; SCr, serum creatinine

1

Kruskal-Wallis test.